Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Significant Decrease in Short Interest

Posted by Mark Dietrich on Mar 1st, 2026

Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the target of a significant decline in short interest during the month of February. As of February 13th, there was short interest totaling 4,350 shares, a decline of 37.8% from the January 29th total of 6,992 shares. Based on an average trading volume of 14,397 shares, the short-interest ratio is currently 0.3 days. Based on an average trading volume of 14,397 shares, the short-interest ratio is currently 0.3 days.

Carl Zeiss Meditec Price Performance

OTCMKTS:CZMWY traded down $0.31 on Friday, reaching $31.92. The company’s stock had a trading volume of 1,546 shares, compared to its average volume of 6,568. Carl Zeiss Meditec has a 12-month low of $29.92 and a 12-month high of $76.28. The stock has a 50 day moving average price of $39.11 and a 200 day moving average price of $46.62.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CZMWY shares. Sanford C. Bernstein cut Carl Zeiss Meditec to a “market perform” rating in a report on Monday, January 26th. The Goldman Sachs Group downgraded Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a research note on Tuesday, January 20th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Carl Zeiss Meditec has an average rating of “Hold”.

View Our Latest Research Report on Carl Zeiss Meditec

About Carl Zeiss Meditec

(Get Free Report)

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.